Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06094257 · ClinicalTrials.gov registry record

Prospective Study of Sensation and Satisfaction in Cancer and Transgender Mastectomy Patients

A clinical trial of Pain, Postoperative and Pain, Chronic, sponsored by Weill Medical College of Cornell University.

Recruiting
Registry status
400
Enrollment target
2
Study locations

NCT06094257: Recruiting study of Pain, Postoperative and Pain, Chronic, sponsored by Weill Medical College of Cornell University.

NCT06094257 is a study of Pain, Postoperative and Pain, Chronic that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 400 participants, above the 269-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (49% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06094257, a study of Pain, Postoperative and Pain, Chronic, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.

RECRUITING
Registry status
400 participants
Enrollment target
2
Study locations

Study Summary

During breast surgery, sensory nerves are cut which may lead to reduced sensation and pain. Surgical reinnervation techniques have been developed with the aim of improving postoperative sensation by preserving the nerves and connecting them to the nipple and areola. The investigators aim to compare postoperative sensation and patient reported outcomes in patients undergoing reinnervation versus those not undergoing reinnervation to determine if there is a difference. The investigators will investigate this in patients undergoing gender-affirming mastectomy, implant-based breast reconstruction and autologous breast reconstruction. The investigators will use various tools that measure sensation quantitatively.

Primary Outcome

All BREAST-Q scores range from 0-100. The scores are computed from the responses to the separate questions by adding them together and converting the score to a scale from 0 to 100 (similar to conversion into a percentage). A higher score means high satisfaction or better health-related quality of life.

Interventions

  • DIAGNOSTIC_TEST Sensory testing

Study Locations (2)

Massachusetts

  • Massachusetts General Hospital - Boston

New York

  • Weill Cornell Medicine - New York

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2022-02-09
Est. Completion 2033-03

What NCT06094257 shows while recruiting

NCT06094257 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, above the 269-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (49% higher).

The record links to 9 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 1 intervention - of which Sensory testing is the first listed.

NCT06094257 reports a single indexed study location in Massachusetts, New York.

Frequently Asked Questions

What is clinical trial NCT06094257 about?

NCT06094257 is a clinical study titled "Prospective Study of Sensation and Satisfaction in Cancer and Transgender Mastectomy Patients". During breast surgery, sensory nerves are cut which may lead to reduced sensation and pain. Surgical reinnervation techniques have been developed with the aim of improving postoperative sensation by preserving the nerves and connecting them to the nipple and areola. The investigators aim to compare ...

What is the current status of trial NCT06094257?

This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2022-02-09. Estimated completion is 2033-03.

What conditions does trial NCT06094257 study?

This clinical trial studies the following conditions: Pain, Postoperative, Pain, Chronic, Sensation Disorders, Phantom Pain, Phantom Sensation.

What interventions are being tested in trial NCT06094257?

The interventions under investigation include: Sensory testing (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06094257?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06094257 being conducted?

This trial has 2 study locations across Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Postoperative

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06094257's enrollment target sits among peer trials

400 9th of 113 higher than 105 of 113 other Pain, Postoperative trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06094257, the US trial registry maintained by the National Library of Medicine. NCT06094257 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.